Table 4.
Bleeding rate according to aspirin use at the time of biopsy
| Aspirin status | Total [n = 2536 (no aspirin, n = 1182; aspirin, n = 327)] |
Elective [total, n = 1499 (no aspirin, n = 692; aspirin, n = 207)] |
Emergency [total, n = 1064 (no aspirin, n = 490; aspirin, n = 120)] |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Death | Tfusion | Embn | Major bleed | Death | Tfusion | Embn | Major bleed | Death | Tfusion | Embn | Major bleed | |
| No aspirin | 1 (0.1%) | 22 (1.9%) | 7 (0.6%) | 30 (2.5%) | 1 (0.1%) | 11 (1.6%) | 2 (0.3%) | 14 (2.0%) | 0 (0.0%) | 11 (2.2%) | 5 (1.0%) | 16 (3.3%) |
| Aspirin | 0 (0.0%) | 5 (1.5%) | 0 (0.0%) | 5 (1.6%) | 0 (0.0%) | 2 (1.0%) | 0 (0.0%) | 2 (1.0%) | 0 (0.0%) | 3 (2.5%) | 0 (0.0%) | 3 (2.5%) |
| Unknown | 0 (0.0%) | 19 (1.8%) | 2 (0.2%) | 21 (2.0%) | 0 (0.0%) | 1 (0.2%) | 0 (0.0%) | 1 (0.2%) | 0 (0.0%) | 18 (4.0%) | 2 (0.4%) | 20 (4.4%) |
| P-value (chi-square) | 0.56 | 0.92 | 0.14 | 0.47 | 0.56 | 0.03 | 0.31 | 0.01 | 0.29 | 0.35 | 0.50 | |
Tfusion, transfusion; Embn, embolization.